Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 5/20 | 0.54 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
| ▸ | CETP | P11597 | 1/20 | 0.46 |
| ▸ | LPL | P06858 | 1/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11849637 | 0.93 | PPARA (0.60) | PPARAPPARGPLK1GGPS1CNR1 | |
| SCHEMBL29209337 | 0.88 | PPARA (0.52) | PPARAPPARGPLK1GGPS1CETP | |
| SCHEMBL8956417 | 0.88 | GGPS1 (0.61) | GGPS1CNR1CNR2 | |
| SCHEMBL8956415 | 0.88 | GGPS1 (0.61) | GGPS1CNR1CNR2 | |
| SCHEMBL8956899 | 0.88 | GGPS1 (0.61) | GGPS1CNR1CNR2 | |
| SCHEMBL8956369 | 0.86 | GGPS1 (0.57) | GGPS1 | |
| SCHEMBL15638466 | 0.85 | PLK1 (0.65) | PPARAPPARGPLK1GGPS1CNR1 | |
| SCHEMBL9165055 | 0.84 | GGPS1 (0.51) | PPARAPPARGPLK1GGPS1CETP | |
| SCHEMBL10901224 | 0.84 | PLK1 (0.63) | PPARAPPARGPLK1GGPS1CNR1 | |
| SCHEMBL10901213 | 0.84 | PLK1 (0.63) | PPARAPPARGPLK1GGPS1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0374513-B1 | Novel bis-arylphosphate ester antagonists of platelet activating factor | AMERICAN CYANAMID CO (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5328901-A | Respiratory system disorders | AMERICAN CYANAMID COMPANY (US) | 1994-07-12 | — | — | US | disclosed |
| US-5231091-A | Antihistamines, anaphylactic, respiratory system disorders, cardiovascular disorders ans septic shock | AMERICAN CYANAMID COMPANY (US) | 1993-07-27 | — | — | US | disclosed |
| US-5147864-A | Bronchodilator agent, antianaphylactic agent, antishock agent, cardiotonic agent and anticarcinogenic agent | AMERICAN CYANAMID COMPANY (US) | 1992-09-15 | — | — | US | disclosed |
| US-4983592-A | Bis-arylphosphate ester antagonists of platelet activating factor | AMERICAN CYANAMID CO. (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0374513-A2 | Novel bis-arylphosphate ester antagonists of platelet activating factor | AMERICAN CYANAMID COMPANY (US) | 1990-06-27 | — | — | EP | disclosed |